Literature DB >> 27546365

Trefoil factor 3 (TFF3) from human breast milk activates PAR-2 receptors, of the intestinal epithelial cells HT-29, regulating cytokines and defensins.

G J Barrera, G Sanchez Tortolero.   

Abstract

Trefoil factors are effector molecules in gastrointestinal tract physiology. Each one improves healing of the gastrointestinal tract. Trefoil factors may be grouped into three classes: the gastric peptides (TFF1), spasmolytic peptide (TFF2) and intestinal trefoil factor (TFF3). Significant amounts of TFF3 are present in human breast milk. Previously, we have reported that trefoil factor 3 isolated from human breast milk produces down regulation of cytokines and promotes human beta defensins expression in intestinal epithelial cells. This study aimed to determine the molecular mechanism involved. Here we showed that the presence of TFF3 strongly correlated with protease activated receptors 2 (PAR-2) activation in human intestinal cells. Intracellular calcium ((Ca2+)i)mobilization was induced by the treatment with: 1) TFF3, 2) synthetic PAR-2 agonist peptide. The co-treatment with a synthetic PAR-2 antagonist peptide and TFF3 eliminates the latter's effect. Additionally, we demonstrated the existence of interactions among TFF3 and PAR-2 receptors through far Western blot and co-precipitation. Finally, down regulation of PAR-2 by siRNA resulted in a decrease of TFF3 induced intracellular (Ca2+)i mobilization, cytokine regulation and defensins expression. These findings suggest that TFF3 activates intestinal cells through PAR-2 (Fig. 4, Ref. 19).

Entities:  

Keywords:  breast milk; cytokines.; defensins; protease-activated receptor 2 PAR-2; trefoil factor family TFF

Mesh:

Substances:

Year:  2016        PMID: 27546365     DOI: 10.4149/bll_2016_066

Source DB:  PubMed          Journal:  Bratisl Lek Listy        ISSN: 0006-9248            Impact factor:   1.278


  9 in total

Review 1.  Structure, Function, and Therapeutic Potential of the Trefoil Factor Family in the Gastrointestinal Tract.

Authors:  Nayara Braga Emidio; Stuart M Brierley; Christina I Schroeder; Markus Muttenthaler
Journal:  ACS Pharmacol Transl Sci       Date:  2020-06-09

Review 2.  Gut homeostasis, injury, and healing: New therapeutic targets.

Authors:  Sema Oncel; Marc D Basson
Journal:  World J Gastroenterol       Date:  2022-05-07       Impact factor: 5.374

Review 3.  Innate Immunity and Breast Milk.

Authors:  Nicole Theresa Cacho; Robert M Lawrence
Journal:  Front Immunol       Date:  2017-05-29       Impact factor: 7.561

Review 4.  Trefoil Factor Family (TFF) Peptides and Their Diverse Molecular Functions in Mucus Barrier Protection and More: Changing the Paradigm.

Authors:  Werner Hoffmann
Journal:  Int J Mol Sci       Date:  2020-06-25       Impact factor: 5.923

5.  Pretreatment with intestinal trefoil factor alleviates stress-induced gastric mucosal damage via Akt signaling.

Authors:  Yun Huang; Meng-Meng Wang; Zhi-Zhou Yang; Yi Ren; Wei Zhang; Zhao-Rui Sun; Shi-Nan Nie
Journal:  World J Gastroenterol       Date:  2020-12-28       Impact factor: 5.742

Review 6.  Pathological and therapeutic roles of bioactive peptide trefoil factor 3 in diverse diseases: recent progress and perspective.

Authors:  Yiqi Yang; Ziyang Lin; Quanyou Lin; Weijian Bei; Jiao Guo
Journal:  Cell Death Dis       Date:  2022-01-17       Impact factor: 8.469

Review 7.  Trefoil Factor Family: Unresolved Questions and Clinical Perspectives.

Authors:  Nayara Braga Emidio; Werner Hoffmann; Stuart M Brierley; Markus Muttenthaler
Journal:  Trends Biochem Sci       Date:  2019-02-18       Impact factor: 13.807

Review 8.  Trefoil Factor Family (TFF) Peptides and Their Links to Inflammation: A Re-evaluation and New Medical Perspectives.

Authors:  Werner Hoffmann
Journal:  Int J Mol Sci       Date:  2021-05-06       Impact factor: 5.923

9.  Trefoil Factor 1 Suppresses Epithelial-mesenchymal Transition through Inhibition of TGF-beta Signaling in Gastric Cancer Cells.

Authors:  Da-Young Lee; Moon-Young Song; Eun-Hee Kim
Journal:  J Cancer Prev       Date:  2021-06-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.